Health
Babies with rare muscle disease can now get ‘life-changer’ drug on the NHS – BBC Focus Magazine
Patients with spinal muscular atrophy will be able to access Zolgensma, a one-time gene therapy, said NHS England.

Up to 80 babies a year are born with a rare muscle-wasting disease and now they could receive life-changing treatment, after the most expensive drug in the world was licensed for use on the NHS in England.
Infants born with spinal muscular atrophy (SMA), an often fatal condition which affects the spinal cord nerves causing paralysis, will be able to access Zolgensma, a one-time gene therapy, said NHS England. The drug, which replicates a missing gene and restores nerve and muscle function, has a…
-
Noosa News22 hours ago
Woman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News21 hours ago
Working for someone else made it hard to care for my daughter. So I quit
-
Business7 hours ago
Ford CEO makes stunning prediction about artificial intelligence
-
General17 hours ago
‘Potential’ hacker contacts Qantas over data breach